Kingdon Capital Management L.L.C. Buys 500,000 Shares of enVVeno Medical Corporation $NVNO

Kingdon Capital Management L.L.C. grew its stake in shares of enVVeno Medical Corporation (NASDAQ:NVNO) by 58.2% during the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 1,359,261 shares of the company’s stock after buying an additional 500,000 shares during the period. Kingdon Capital Management L.L.C. owned 6.72% of enVVeno Medical worth $1,232,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also recently modified their holdings of the company. Jane Street Group LLC bought a new position in shares of enVVeno Medical in the second quarter valued at approximately $51,000. Creative Planning purchased a new stake in enVVeno Medical in the 2nd quarter worth approximately $54,000. Geode Capital Management LLC boosted its holdings in enVVeno Medical by 1.1% in the 2nd quarter. Geode Capital Management LLC now owns 199,509 shares of the company’s stock valued at $796,000 after purchasing an additional 2,211 shares during the period. Universal Beteiligungs und Servicegesellschaft mbH purchased a new position in shares of enVVeno Medical during the 2nd quarter valued at $798,000. Finally, CM Management LLC bought a new position in shares of enVVeno Medical in the third quarter worth $544,000. 34.71% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

Separately, Weiss Ratings reissued a “sell (e+)” rating on shares of enVVeno Medical in a research note on Monday, December 29th. One equities research analyst has rated the stock with a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat, enVVeno Medical currently has an average rating of “Reduce”.

enVVeno Medical Price Performance

Shares of enVVeno Medical stock opened at $10.61 on Monday. enVVeno Medical Corporation has a 1 year low of $8.67 and a 1 year high of $196.70. The firm has a market cap of $7.00 million, a PE ratio of -0.28 and a beta of 1.12. The company has a 50 day simple moving average of $10.92 and a two-hundred day simple moving average of $18.02.

enVVeno Medical Company Profile

enVVeno Medical, Inc is a clinical‐stage medical device company focused on the development and commercialization of subcutaneous vascular access systems for patients requiring repeated or long‐term intravenous therapy. Through its proprietary Freedom® platform, the company aims to offer an implantable alternative to traditional peripherally inserted central catheters (PICCs) and external tunneled catheters, addressing complications such as infection risk, dislodgement and patient discomfort.

The company’s lead product candidate, the Freedom PICC System, consists of a low‐profile, subcutaneous port connected to a flexible catheter designed for peripheral insertion.